How does Latvia rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)?

In 2021, Latvia ranked #17 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%).

Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)

Name: Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
Creator: World Bank
License: https://datacatalog.worldbank.org/public-licenses#cc-by

In 2021, Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) was 33.30.

That's up 8.8% from 2020, the highest value since 2014.

The global average for this indicator in 2021 was 21.54 . Latvia ranks #17 globally out of 185 reporting countries. Within Europe & Central Asia, it ranks #5 of 48.

Source: World Bank Open Data (SH.DYN.NCOM.MA.ZS) • Data as of 2021

Trend (2002–2021)

2020 · COVID-19 pandemic
2004 · EU enlargement (10 new members)

Highlights

Peak: 41.70; 2005
Trough: 30.60; 2019
1-year change: +8.8%
5-year change: +3.7%; +0.7% / yr
10-year change: -8.5%; -0.9% / yr

Historical Data — Last 10 Years

Year	Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
2021	33.3000
2020	30.6000
2019	30.6000
2018	31.8000
2017	32.5000
2016	32.1000
2015	31.9000
2014	34.1000
2013	34.4000
2012	35.2000

About Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Indicator code: SH.DYN.NCOM.MA.ZS • Category: Health & Population

Frequently asked questions

What was Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in 2021?: In 2021, Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) was 33.30, according to World Bank Open Data.
Is Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) rising or falling?: Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) rose 8.8% from 2020 to 2021.
How does Latvia rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)?: In 2021, Latvia ranked #17 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%).
How does Latvia's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) compare to the world average?: The global average for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in 2021 was 21.54, so Latvia is above the world average. Within Europe & Central Asia, it ranks #5 of 48.
What is Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) and how is it measured?: Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Download this data: CSV JSON

Source: World Bank Open Data (SH.DYN.NCOM.MA.ZS), CC BY 4.0.